Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TELA Bio (TELA) Equity Average (2018 - 2025)

TELA Bio has reported Equity Average over the past 8 years, most recently at $3.9 million for Q4 2025.

  • Quarterly results put Equity Average at $3.9 million for Q4 2025, down 64.53% from a year ago — trailing twelve months through Dec 2025 was $3.9 million (down 64.53% YoY), and the annual figure for FY2025 was $17.4 million, down 26.55%.
  • Equity Average for Q4 2025 was $3.9 million at TELA Bio, down from $5.4 million in the prior quarter.
  • Over the last five years, Equity Average for TELA hit a ceiling of $45.4 million in Q1 2021 and a floor of -$1.7 million in Q3 2024.
  • Median Equity Average over the past 5 years was $15.9 million (2022), compared with a mean of $18.0 million.
  • Biggest five-year swings in Equity Average: crashed 104.82% in 2024 and later soared 415.73% in 2025.
  • TELA Bio's Equity Average stood at $23.9 million in 2021, then fell by 21.37% to $18.8 million in 2022, then surged by 31.45% to $24.7 million in 2023, then tumbled by 55.12% to $11.1 million in 2024, then plummeted by 64.53% to $3.9 million in 2025.
  • The last three reported values for Equity Average were $3.9 million (Q4 2025), $5.4 million (Q3 2025), and $13.7 million (Q2 2025) per Business Quant data.